newscontact us

CESCA TO EXHIBIT AT THE 25th INTERNATIONAL SOCIETY FOR CELLULAR THERAPY (ISCT) ANNUAL MEETING

RANCHO CORDOVA, CA, May 2, 2017 – Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that ThermoGenesis, the company’s device subsidiary, will showcase its AutoXpress cellular bioprocessing and BioArchive cryopreservation solutions at the 2017 International Society for Cellular Therapy (ISCT) Annual Meeting being held May 3-6 at the ExCel London Conference Center in London, U.K…(more)